These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16061457)

  • 21. Prescription drug abuse among prisoners in rural Southwestern Virginia.
    Wunsch MJ; Nakamoto K; Goswami A; Schnoll SH
    J Addict Dis; 2007; 26(4):15-22. PubMed ID: 18032228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between non-medical and prescriptive usage of opioids.
    Dasgupta N; Kramer ED; Zalman MA; Carino S; Smith MY; Haddox JD; Wright C
    Drug Alcohol Depend; 2006 Apr; 82(2):135-42. PubMed ID: 16236466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exploratory study of OxyContin use among individuals with substance use disorders.
    Levy MS
    J Psychoactive Drugs; 2007 Sep; 39(3):271-6. PubMed ID: 18159780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study.
    Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B
    Drug Alcohol Depend; 2015 Jun; 151():56-67. PubMed ID: 25910850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey.
    Smith MY; Haddox JD; Di Marino ME
    J Pain Palliat Care Pharmacother; 2007; 21(3):5-17. PubMed ID: 18032351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study.
    Pletcher MJ; Kertesz SG; Sidney S; Kiefe CI; Hulley SB
    Drug Alcohol Depend; 2006 Nov; 85(2):171-6. PubMed ID: 16723193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid analgesics and rates of fatal drug poisoning in the United States.
    Paulozzi LJ; Ryan GW
    Am J Prev Med; 2006 Dec; 31(6):506-11. PubMed ID: 17169712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
    Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
    J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
    Martins SS; Storr CL; Zhu H; Chilcoat HD
    Drug Alcohol Depend; 2009 Jan; 99(1-3):58-67. PubMed ID: 18706774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity.
    Manchikanti L; Brown KR; Singh V
    Pain Physician; 2002 Jul; 5(3):294-319. PubMed ID: 16902657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA actions to prevent prescription drug abuse.
    Jeske AH
    Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888
    [No Abstract]   [Full Text] [Related]  

  • 37. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.
    Young AM; Havens JR
    Addiction; 2012 Mar; 107(3):587-96. PubMed ID: 21883604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
    Severtson SG; Ellis MS; Kurtz SP; Rosenblum A; Cicero TJ; Parrino MW; Gilbert MK; Buttram ME; Dasgupta N; BucherBartelson B; Green JL; Dart RC
    Drug Alcohol Depend; 2016 Nov; 168():219-229. PubMed ID: 27716575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
    Cone EJ; Fant RV; Rohay JM; Caplan YH; Ballina M; Reder RF; Haddox JD
    J Anal Toxicol; 2004 Oct; 28(7):616-24. PubMed ID: 15516322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.
    Cone EJ; Fant RV; Rohay JM; Caplan YH; Ballina M; Reder RF; Haddox JD
    J Anal Toxicol; 2004; 28(4):217-25. PubMed ID: 15189671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.